Review



fgf23 monoclonal antibody  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress fgf23 monoclonal antibody
    Fgf23 Monoclonal Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/Burosumab/pm41972542-48-1-7
    Average 94 stars, based on 2 article reviews
    fgf23 monoclonal antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Injection:

    Article Title: FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice.
    Article Snippet: .. For FGF23 monoclonal antibody (FGF23 mAb, #HY-P9939; MCE, Monmouth Junction, NJ, USA) treatment, 16 mg/kg FGF23 mAb was subcutaneously injected once a week after TAC operation [18]. .. Recombinant FGF23 (rFGF23) was purchased from Ipodix Biotechnology Engineering Co., Ltd. (#PA1000-8189; Wuhan, China) and was subcutaneously injected every two days after TAC operation at the dose of 0.5 mg/kg [19].

    Article Title: FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice
    Article Snippet: .. For FGF23 monoclonal antibody (FGF23 mAb, #HY-P9939; MCE, Monmouth Junction, NJ, USA) treatment, 16 mg/kg FGF23 mAb was subcutaneously injected once a week after TAC operation [ ]. .. Recombinant FGF23 (rFGF23) was purchased from Ipodix Biotechnology Engineering Co., Ltd. (#PA1000-8189; Wuhan, China) and was subcutaneously injected every two days after TAC operation at the dose of 0.5 mg/kg [ ].



    Similar Products

    fgf23 monoclonal antibody  (MedChemExpress)
    94
    MedChemExpress fgf23 monoclonal antibody
    Fgf23 Monoclonal Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/Burosumab/pm41972542-48-1-7
    Average 94 stars, based on 1 article reviews
    fgf23 monoclonal antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human fgf23 monoclonal antibody  (R&D Systems)
    93
    R&D Systems human fgf23 monoclonal antibody
    (A) displays the distribution of post-KT <t>FGF23</t> levels based on the hypertension status. (B) shows that the patients with larger LA volumes had the worst NHYA class.
    Human Fgf23 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/Human+FGF-23+Antibody/pmc11922888-138-6-11
    Average 93 stars, based on 1 article reviews
    human fgf23 monoclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mouse anti human fgf23 monoclonal antibody nbp3-07378  (Novus Biologicals)
    90
    Novus Biologicals mouse anti human fgf23 monoclonal antibody nbp3-07378
    (A) displays the distribution of post-KT <t>FGF23</t> levels based on the hypertension status. (B) shows that the patients with larger LA volumes had the worst NHYA class.
    Mouse Anti Human Fgf23 Monoclonal Antibody Nbp3 07378, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/mouse+anti+human+fgf23+monoclonal/pmc11015760-88-6-13
    Average 90 stars, based on 1 article reviews
    mouse anti human fgf23 monoclonal antibody nbp3-07378 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mouse anti­human fgf23 monoclonal antibody  (Novus Biologicals)
    94
    Novus Biologicals mouse anti­human fgf23 monoclonal antibody
    (A) IHC indicated the expression levels of <t>FGF23</t> in the UNSM, ULM, and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among six paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples. US, uterine sarcoma; IHC, immunohistochemistry; UNSM, uterine normal smooth muscle; ULM, uterine leiomyoma.
    Mouse Anti­Human Fgf23 Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/FGF-23+Antibody+(FGF23%2F4168)/pmc11015760-88-6-12
    Average 94 stars, based on 1 article reviews
    mouse anti­human fgf23 monoclonal antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    rat monoclonal anti-fgf23 neutralizing antibody  (Amgen)
    90
    Amgen rat monoclonal anti-fgf23 neutralizing antibody
    (A) IHC indicated the expression levels of <t>FGF23</t> in the UNSM, ULM, and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among six paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples. US, uterine sarcoma; IHC, immunohistochemistry; UNSM, uterine normal smooth muscle; ULM, uterine leiomyoma.
    Rat Monoclonal Anti Fgf23 Neutralizing Antibody, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/rat+anti+fgf23+primary+antibody/pm37972265-50-3-10
    Average 90 stars, based on 1 article reviews
    rat monoclonal anti-fgf23 neutralizing antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    monoclonal mouse anti human fgf23 antibody  (R&D Systems)
    93
    R&D Systems monoclonal mouse anti human fgf23 antibody
    Figure 1. Dependence of the SPRi signal on <t>FGF23</t> antibody concentration. The used concentration of the FGF23-αKlotho complex was 40:169.2 pg/mL; pH = 7.4. “Standard deviation (SD)” was calculated from 12 individual measurements.
    Monoclonal Mouse Anti Human Fgf23 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/Human+FGF-23+Antibody/pm37895007-201-1-6
    Average 93 stars, based on 1 article reviews
    monoclonal mouse anti human fgf23 antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    mouse anti human fgf23 monoclonal antibody  (Novus Biologicals)
    94
    Novus Biologicals mouse anti human fgf23 monoclonal antibody
    (A) IHC indicated the expression levels of <t>FGF23</t> in the UNSM, ULM and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among 6 paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples.
    Mouse Anti Human Fgf23 Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/FGF-23+Antibody+(FGF23%2F4168)/med_rxiv__2023__08__20__23294198-43-5-11
    Average 94 stars, based on 1 article reviews
    mouse anti human fgf23 monoclonal antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    ab 2722759 rat monoclonal anti fgf23 mab26291 r d systems  (R&D Systems)
    93
    R&D Systems ab 2722759 rat monoclonal anti fgf23 mab26291 r d systems
    (A) IHC indicated the expression levels of <t>FGF23</t> in the UNSM, ULM and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among 6 paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples.
    Ab 2722759 Rat Monoclonal Anti Fgf23 Mab26291 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgf23+monoclonal+antibody/Mouse+FGF-23+Antibody/pm36718587-112-26-31
    Average 93 stars, based on 1 article reviews
    ab 2722759 rat monoclonal anti fgf23 mab26291 r d systems - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) displays the distribution of post-KT FGF23 levels based on the hypertension status. (B) shows that the patients with larger LA volumes had the worst NHYA class.

    Journal: Frontiers in Nephrology

    Article Title: Role of kidney transplantation in long-term cardiac reverse remodeling and interconnecting mechanisms in type 4 cardiorenal syndrome

    doi: 10.3389/fneph.2024.1455036

    Figure Lengend Snippet: (A) displays the distribution of post-KT FGF23 levels based on the hypertension status. (B) shows that the patients with larger LA volumes had the worst NHYA class.

    Article Snippet: FGF23 levels were quantified using the Human FGF23 monoclonal antibody and R&D Systems reagent (Minneapolis, MN, USA).

    Techniques:

    Biochemical and echocardiographic characteristics grouped according the basal LVEF and after KT.

    Journal: Frontiers in Nephrology

    Article Title: Role of kidney transplantation in long-term cardiac reverse remodeling and interconnecting mechanisms in type 4 cardiorenal syndrome

    doi: 10.3389/fneph.2024.1455036

    Figure Lengend Snippet: Biochemical and echocardiographic characteristics grouped according the basal LVEF and after KT.

    Article Snippet: FGF23 levels were quantified using the Human FGF23 monoclonal antibody and R&D Systems reagent (Minneapolis, MN, USA).

    Techniques:

    (A) IHC indicated the expression levels of FGF23 in the UNSM, ULM, and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among six paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples. US, uterine sarcoma; IHC, immunohistochemistry; UNSM, uterine normal smooth muscle; ULM, uterine leiomyoma.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma

    doi: 10.1177/15330338241245924

    Figure Lengend Snippet: (A) IHC indicated the expression levels of FGF23 in the UNSM, ULM, and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among six paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples. US, uterine sarcoma; IHC, immunohistochemistry; UNSM, uterine normal smooth muscle; ULM, uterine leiomyoma.

    Article Snippet: Immunohistochemistry (IHC) was performed using a mouse anti­human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing, Immunohistochemistry

    (A) IHC assay indicated FGF23 expression in different uterine sarcoma subtypes. (B) The box plot and scatter plot shows the differential expression of FGF23 in AS, ESS, LMS, and UCS. FGF23 intensity: 1+ = weak, 2+ = moderate, 3+ = strong, FGF23 expression: 1+ = 1-25%, 2+ = 25-50%, 3+ = 50-75%, 4+ = ＞75%. IHC, immunohistochemistry; UCS, uterine carcinosarcoma; LMS, leiomyosarcoma; ESS, endometrial stromal sarcoma; AS, adenosarcoma.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma

    doi: 10.1177/15330338241245924

    Figure Lengend Snippet: (A) IHC assay indicated FGF23 expression in different uterine sarcoma subtypes. (B) The box plot and scatter plot shows the differential expression of FGF23 in AS, ESS, LMS, and UCS. FGF23 intensity: 1+ = weak, 2+ = moderate, 3+ = strong, FGF23 expression: 1+ = 1-25%, 2+ = 25-50%, 3+ = 50-75%, 4+ = ＞75%. IHC, immunohistochemistry; UCS, uterine carcinosarcoma; LMS, leiomyosarcoma; ESS, endometrial stromal sarcoma; AS, adenosarcoma.

    Article Snippet: Immunohistochemistry (IHC) was performed using a mouse anti­human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing, Immunohistochemistry

    (A) K-M analysis suggested overall survival of FGF23 high or low expression in 41 UCS patients from the TCGA cohort. (B) K-M analysis revealed the overall survival by FGF23 high or low expression in 50 UUS patients from the GEO database. (C) K-M analysis indicated no significant correlation between FGF23 expression levels and OS or PFS of US patients from the Suining cohort. (D) K-M analysis showed the differential OS and PFS between LG-ESS and other types of US patients from the Suining cohort. US, uterine sarcoma; TCGA, The Cancer Genome Atlas; FGF23, fibroblast growth factor 23; GEO, Gene Expression Omnibus; UCS, uterine carcinosarcoma; OS, overall survival; PFS, progression-free survival; LG-ESS, low-grade endometrial stromal sarcoma; UUS, undifferentiated uterine sarcoma.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma

    doi: 10.1177/15330338241245924

    Figure Lengend Snippet: (A) K-M analysis suggested overall survival of FGF23 high or low expression in 41 UCS patients from the TCGA cohort. (B) K-M analysis revealed the overall survival by FGF23 high or low expression in 50 UUS patients from the GEO database. (C) K-M analysis indicated no significant correlation between FGF23 expression levels and OS or PFS of US patients from the Suining cohort. (D) K-M analysis showed the differential OS and PFS between LG-ESS and other types of US patients from the Suining cohort. US, uterine sarcoma; TCGA, The Cancer Genome Atlas; FGF23, fibroblast growth factor 23; GEO, Gene Expression Omnibus; UCS, uterine carcinosarcoma; OS, overall survival; PFS, progression-free survival; LG-ESS, low-grade endometrial stromal sarcoma; UUS, undifferentiated uterine sarcoma.

    Article Snippet: Immunohistochemistry (IHC) was performed using a mouse anti­human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing

    Figure 1. Dependence of the SPRi signal on FGF23 antibody concentration. The used concentration of the FGF23-αKlotho complex was 40:169.2 pg/mL; pH = 7.4. “Standard deviation (SD)” was calculated from 12 individual measurements.

    Journal: International journal of molecular sciences

    Article Title: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.

    doi: 10.3390/ijms242015327

    Figure Lengend Snippet: Figure 1. Dependence of the SPRi signal on FGF23 antibody concentration. The used concentration of the FGF23-αKlotho complex was 40:169.2 pg/mL; pH = 7.4. “Standard deviation (SD)” was calculated from 12 individual measurements.

    Article Snippet: The monoclonal mouse anti-human FGF23 antibody (R&D Systems) was a receptor that bound the FGF23 protein from samples to the chip’s surface.

    Techniques: Concentration Assay, Standard Deviation

    Figure 2. Dependence of the SPRi signal on the FGF23 concentration. The used FGF23 antibody concentration is 25 ng/mL; pH = 7.4. SD was calculated from 12 individual measurements.

    Journal: International journal of molecular sciences

    Article Title: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.

    doi: 10.3390/ijms242015327

    Figure Lengend Snippet: Figure 2. Dependence of the SPRi signal on the FGF23 concentration. The used FGF23 antibody concentration is 25 ng/mL; pH = 7.4. SD was calculated from 12 individual measurements.

    Article Snippet: The monoclonal mouse anti-human FGF23 antibody (R&D Systems) was a receptor that bound the FGF23 protein from samples to the chip’s surface.

    Techniques: Concentration Assay

    Figure 3. Dependence of the SPRi signal on the FGF23 concentration with the addition of αKlotho protein. The used FGF23 antibody concentration is 25 ng/mL; pH = 7.4. SD was calculated from 12 individual measurements.

    Journal: International journal of molecular sciences

    Article Title: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.

    doi: 10.3390/ijms242015327

    Figure Lengend Snippet: Figure 3. Dependence of the SPRi signal on the FGF23 concentration with the addition of αKlotho protein. The used FGF23 antibody concentration is 25 ng/mL; pH = 7.4. SD was calculated from 12 individual measurements.

    Article Snippet: The monoclonal mouse anti-human FGF23 antibody (R&D Systems) was a receptor that bound the FGF23 protein from samples to the chip’s surface.

    Techniques: Concentration Assay

    Figure 4. Formation of the FGF23 SPRi biosensor layers, i.e., bare gold, cysteamine, FGF23 antibody, and FGF23-αKlotho complex, captured via SEM. Used parameters: 12.5 or 15 kV, and 100,000× magnification.

    Journal: International journal of molecular sciences

    Article Title: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.

    doi: 10.3390/ijms242015327

    Figure Lengend Snippet: Figure 4. Formation of the FGF23 SPRi biosensor layers, i.e., bare gold, cysteamine, FGF23 antibody, and FGF23-αKlotho complex, captured via SEM. Used parameters: 12.5 or 15 kV, and 100,000× magnification.

    Article Snippet: The monoclonal mouse anti-human FGF23 antibody (R&D Systems) was a receptor that bound the FGF23 protein from samples to the chip’s surface.

    Techniques:

    Figure 6. Scheme of the measuring system of the SPRi apparatus and an overview diagram of the FGF23 biosensor.

    Journal: International journal of molecular sciences

    Article Title: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.

    doi: 10.3390/ijms242015327

    Figure Lengend Snippet: Figure 6. Scheme of the measuring system of the SPRi apparatus and an overview diagram of the FGF23 biosensor.

    Article Snippet: The monoclonal mouse anti-human FGF23 antibody (R&D Systems) was a receptor that bound the FGF23 protein from samples to the chip’s surface.

    Techniques:

    (A) IHC indicated the expression levels of FGF23 in the UNSM, ULM and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among 6 paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples.

    Journal: medRxiv

    Article Title: FGF23 is a potential prognostic biomarker in uterine sarcoma

    doi: 10.1101/2023.08.20.23294198

    Figure Lengend Snippet: (A) IHC indicated the expression levels of FGF23 in the UNSM, ULM and US groups. (B) The box plot shows FGF23 expression in US, ULM, and UNSM among 6 paired samples. (C) The box plot shows FGF23 expression in US and UNSM among 32 paired samples.

    Article Snippet: Immunohistochemistry was performed using a mouse anti-human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing

    (A) IHC assay indicated FGF23 expression in different uterine sarcoma subtypes. (B) The box plot shows the differential expression of FGF23 in AS, ESS, LMS and UCS.

    Journal: medRxiv

    Article Title: FGF23 is a potential prognostic biomarker in uterine sarcoma

    doi: 10.1101/2023.08.20.23294198

    Figure Lengend Snippet: (A) IHC assay indicated FGF23 expression in different uterine sarcoma subtypes. (B) The box plot shows the differential expression of FGF23 in AS, ESS, LMS and UCS.

    Article Snippet: Immunohistochemistry was performed using a mouse anti-human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing

    (A) K-M analysis suggested overall survival of FGF23 high or low expression in 41 UCS patients from the TCGA cohort. (B) K-M analysis revealed the overall survival by FGF23 high or low expression in 50 UUS patients from the GEO database. (C) K-M analysis indicated no significant correlation between FGF23 expression levels and OS or PFS of US patients from the clinical cohort. (D) K-M analysis showed the differential OS and PFS between LG-ESS and other types of US patients from the clinical cohort.

    Journal: medRxiv

    Article Title: FGF23 is a potential prognostic biomarker in uterine sarcoma

    doi: 10.1101/2023.08.20.23294198

    Figure Lengend Snippet: (A) K-M analysis suggested overall survival of FGF23 high or low expression in 41 UCS patients from the TCGA cohort. (B) K-M analysis revealed the overall survival by FGF23 high or low expression in 50 UUS patients from the GEO database. (C) K-M analysis indicated no significant correlation between FGF23 expression levels and OS or PFS of US patients from the clinical cohort. (D) K-M analysis showed the differential OS and PFS between LG-ESS and other types of US patients from the clinical cohort.

    Article Snippet: Immunohistochemistry was performed using a mouse anti-human FGF23 monoclonal antibody (NBP3-07378; Novus Biologicals, Colorado, USA).

    Techniques: Expressing